Lyrica CR 165 mg/1

Lyrica CR 165 mg is an extended-release tablet containing pregabalin, used for managing certain types of nerve pain and seizures. This medication is designed for oral administration and is manufactured by Parke-Davis, a division of Pfizer Inc.

Lyrica CR 165 mg is primarily used for the management of neuropathic pain and as an adjunctive therapy for partial seizures. Pregabalin, the active ingredient, is often prescribed for conditions involving nerve damage or dysfunction, which may lead to chronic pain. Patients may wonder, 'What is Lyrica CR used for?' This medication is specifically formulated to provide extended relief, helping to maintain consistent levels of the drug in the body.

Common effects of Lyrica CR 165 mg may include dizziness, drowsiness, and peripheral edema. Some users might experience weight gain or blurred vision. These effects can vary among individuals and may not affect everyone who takes the medication. It's important to monitor how the body responds to this extended-release formulation.

Lyrica CR 165 mg should be handled with care, especially for those with a history of heart or kidney issues. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid activities that require alertness, such as driving, until they know how the medication affects them.

Lyrica CR 165 mg may interact with alcohol and other central nervous system depressants, potentially enhancing sedative effects. It is also important to be cautious when combining this medication with opioids or other drugs that affect the central nervous system. Always consult a healthcare provider before starting or stopping any medication.